Navigation Links
R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients
Date:9/10/2007

- Phase 1 Study Results in 2.7 log10 (>99%) Mean HCV RNA Decrease with No

Serious Adverse Events -

- Conference Call Scheduled for 8:30AM (ET) Today -

PRINCETON, N.J., Sept. 10 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS) reports preliminary safety and potent antiviral activity with R7128 following 14 days of monotherapy in 40 patients chronically infected with hepatitis C virus (HCV) who have failed prior interferon therapy. R7128 is a prodrug of PSI-6130, an oral cytidine nucleoside analog polymerase inhibitor of HCV that is being developed through Pharmasset's collaboration with Roche. The Phase 1 multiple ascending dose study of R7128 was designed to evaluate safety, tolerability, pharmacokinetics and preliminary antiviral activity.

R7128 demonstrated potent, dose-dependent antiviral activity across the four patient cohorts (n=10; 8 active, 2 placebo) receiving 750 mg or 1500 mg administered either once-daily or twice-daily for 14 days as monotherapy. The greatest mean decrease in HCV RNA from baseline was demonstrated in the patient cohort that received 1500 mg twice-daily, the highest dose of R7128 administered in this study. These patients demonstrated a mean 2.7 log10 IU/mL (>99%) decrease in HCV RNA. There was no evidence of viral rebound in any dose cohort during the 14 days of dosing.

R7128 was generally safe and well tolerated in this Phase 1 multiple ascending dose study. There were no serious adverse events, no adverse events requiring dose modification, no dose-related gastrointestinal adverse events and no clinically significant changes in vital signs, electrocardiograms, hematologic, renal or other laboratory parameters.

Base
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
2. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
3. New Research Demonstrates Broad Efficacy of Azixa (MPC-6827) Against Multiple Tumor Types and in Drug Resistant Cell Lines
4. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
5. Gerons Telomerase Inhibitor Cancer Drug Demonstrates Good Pharmacokinetics and Tolerability in Phase I/II Trial
6. Frova Phase III Study Data Demonstrates That Short-Term Prevention Treatment Reduces Frequency and Severity of Menstrual Migraine
7. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
8. Cipralex demonstrates superiority to duloxetine for acute treatment of depression in new study
9. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression
10. Introgens Advexin Demonstrates Clinical Benefit in Inherited Cancer
11. Prostate Cancer: Clinical Study Demonstrates Superior Efficacy of Docetaxel Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... Calif. , Jan. 14, 2014 The Brandeis Medical Center, ... Angeles a premier and affordable laser tattoo removal experience ... Dr. Brandeis, focus is in providing high quality cosmetic services with ... patients. " Southern California has seen ...
(Date:1/14/2014)... Emergency Critical Care, a LifeCentre partner practice, located at 165 Fort ... first in Loudoun County to receive a ... M. Barnes , Medical Director, is a well-seasoned veterinarian of more ... , are avid scuba divers. "As altitude skiers and hikers, we ...
(Date:1/14/2014)... Oligomerix, Inc. , a privately held company pioneering the ... and related neurodegenerative disorders, announced today the relocation of ... as of January 15, 2014 and expanded lease ... College. Oligomerix, which is focused on the ...
Breaking Medicine Technology:Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2Oligomerix Relocates Corporate Headquarters and Secures Additional Laboratory Space from New York Medical College 2
... WOONSOCKET, R.I., Feb. 14, 2012  CVS Caremark (NYSE: ... impact study of CVS Caremark,s contribution to the ... company,s national headquarters is located.  According to the ... for CVS Caremark, the company,s Rhode Island operations ...
... Feb. 14, 2012 Watson Pharmaceuticals, Inc. (NYSE: ... $1.5 billion for the fourth quarter ended December 31, 2011, ... a non-GAAP basis, net income for the fourth quarter 2011 ... 93 percent, compared to $116.5 million or $0.93 per share ...
Cached Medicine Technology:Report: CVS Caremark Contributes Billions to Rhode Island Economy 2Report: CVS Caremark Contributes Billions to Rhode Island Economy 3Watson Full Year 2011 Net Revenue Increases 29% to $4.58 Billion; 2Watson Full Year 2011 Net Revenue Increases 29% to $4.58 Billion; 3Watson Full Year 2011 Net Revenue Increases 29% to $4.58 Billion; 4Watson Full Year 2011 Net Revenue Increases 29% to $4.58 Billion; 5Watson Full Year 2011 Net Revenue Increases 29% to $4.58 Billion; 6Watson Full Year 2011 Net Revenue Increases 29% to $4.58 Billion; 7Watson Full Year 2011 Net Revenue Increases 29% to $4.58 Billion; 8Watson Full Year 2011 Net Revenue Increases 29% to $4.58 Billion; 9Watson Full Year 2011 Net Revenue Increases 29% to $4.58 Billion; 10Watson Full Year 2011 Net Revenue Increases 29% to $4.58 Billion; 11Watson Full Year 2011 Net Revenue Increases 29% to $4.58 Billion; 12Watson Full Year 2011 Net Revenue Increases 29% to $4.58 Billion; 13Watson Full Year 2011 Net Revenue Increases 29% to $4.58 Billion; 14
(Date:4/18/2014)... (April 18, 2014) ― A new study in the ... patterns in health-related Google searches reveals a recurring pattern ... , Investigators from San Diego State University, ... Monday Campaigns, analyzed "healthy" Google searches (searches that included ... diet") originating in the U.S. from 2005 to 2012. ...
(Date:4/18/2014)... scientists could lead to potential new treatments for breaking ... , Fibrosis, or scarring, is a hallmark of ... lungs can lead to serious organ damage and, in ... options centers on findings made by Swati Bhattacharyya, PhD, ... that a specific protein plays in promoting fibrosis. ...
(Date:4/17/2014)... chronic inflammation in non-cancerous prostate tissue may have nearly ... those with no inflammation, according to results of a ... Kimmel Cancer Center. , The link between persistent inflammation ... high-grade prostate cancer those with a Gleason score ... the most aggressive and rapidly growing prostate cancers. , ...
(Date:4/17/2014)... targets that could be used to provide relief ... London made the discovery when researching how pain ... body. , Dr Marzia Malcangio said: "We have ... and our findings could help chemotherapy patients who ... side effect of some chemotherapy drugs (such as ...
(Date:4/17/2014)... According to a study published today in PLOS ... world where malaria is common can mount an immune ... them to avoid repeated bouts of high fever and ... in their bloodstream. The findings may help researchers develop ... by the malaria parasite. , Each year, approximately 200 ...
Breaking Medicine News(10 mins):Health News:New research shows people are thinking about their health early in the week 2Health News:New clues on tissue scarring in scleroderma 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:New pain relief targets discovered 2Health News:Study sheds light on how the immune system protects children from malaria 2
... of dengue fever, taking the death toll in the capital ... hospitals as health officials launched a war against// the mosquito-borne ... number of patients in Delhi rose Friday to 1,278, officials ... Thursday. Though no new measures have been announced and all ...
... a strong role along with maternal age in determining ... have been either contemplating a planned pregnancy or have ... reeling under the heavy load of traditionally handed down ... a pregnancy were the chances of the fetus (unborn ...
... ,According to the ruling by Maryland's highest court a ... state's medical// assistance program by Republican Gov. Robert L. ... unanimously that Ehrlich violated civil rights protections afforded by ... the program that provided health care for 4,000 children ...
... room in the intensive care unit previously ... may increase the odds of acquiring such ... illness and death in hospitals: methicillin-resistant Staphylococcus ... to background information in the article. Researchers ...
... a major handicap to world health and WHO knows it better! ... a world free of polio in a span of one to ... 2005 faced a gap in fructification, sending it off mark by ... boycott sparked off in Northern Nigeria by stiff-necked Islamic clerics in ...
... shut down the neo-natal intensive care unit of the Rizal ... was passed by the Philippine Health Secretary Francisco Duque III ... ,The unfortunate deaths of all the 7 babies ... to uncontrolled bacterial infection in blood or “neo-natal sepsis”. . ...
Cached Medicine News:Health News:Delhi Death Toll Due to Dengue Rises to 24 2Health News:Cause of ‘Down Syndrome’ cannot be pinned down to maternal age alo 2Health News:Health Care Benefits for Immigrants Favored by MD Court 2Health News:Transmission of Antibiotic-Resistant Bacteria Linked to Previous ICU Room Occupants 2
... CardioDirect12-S is the stress testing system from ... turn-key system including treadmill or bicycle ergometer, ... BP option. It uses the same CardioDirect ... resting ECG. ,The system is ...
... monitor, store and measure data during the performance ... organize the amount of information detected during the ... and printout of an extremely flexible final report. ... small portable ECG recorder (ECT 12 no ...
... Marco's CP-690E Automatic Chart Projector makes refracting ... you program up to 33 charts in any ... examination in a darkened room simply by pressing ... to the next chart. In addition, the CP-690E's ...
... Ultimate in Stability. ... stabilizer features superior arm ... in the clamp/turret mechanism. ... features the ultimate flexibility ...
Medicine Products: